Effects of recombinant human erythropoietin in normal humans.
about
Erythropoietin and the use of a transgenic model of erythropoietin-deficient miceCombination of erythropoietin and sildenafil can effectively attenuate hypoxia-induced pulmonary hypertension in mice.Nasal administration of the neuroprotective candidate NeuroEPO to healthy volunteers: a randomized, parallel, open-label safety studyEvaluation of functional erythropoietin receptor status in skeletal muscle in vivo: acute and prolonged studies in healthy human subjectsHaemoglobin mass and running time trial performance after recombinant human erythropoietin administration in trained men.Recombinant erythropoietin in humans has a prolonged effect on circulating erythropoietin isoform distribution.The evolving science of detection of 'blood doping'.Mechanisms governing the health and performance benefits of exercise.Effect of Erythropoietin on Postresuscitation Renal Function in a Swine Model of Ventricular Fibrillation.Prophylactic effect of erythropoietin injection to prevent acute mountain sickness: an open-label randomized controlled trial.Blood doping: potential of blood and urine sampling to detect autologous transfusion.How do we treat life-threatening anemia in a Jehovah's Witness patient?Erythropoietin receptor (EpoR) agonism is used to treat a wide range of disease.Report on an anti-doping operation in Guadeloupe: High number of positive cases and inferences about doping habits.Neuroprotection and endocytosis: erythropoietin receptors in insect nervous systems.Renin cells in homeostasis, regeneration and immune defence mechanisms.Three weeks of erythropoietin treatment hampers skeletal muscle mitochondrial biogenesis in rats.New insights for identification of doping with recombinant human erythropoietin micro-doses after high hydration.Recombinant erythropoietin acutely decreases renal perfusion and decouples the renin-angiotensin-aldosterone system.
P2860
Q28075785-39174B56-7344-411A-8F33-B74A9C5480C8Q33806219-F5B77401-7F75-4E11-A96E-09E879518CF1Q33870071-354C13CB-3D2F-4A1C-B32C-5159302029F2Q34182011-0437A2BD-1DB2-41AA-B584-911D49F1FB71Q34589872-D77BE626-0366-40BB-AEBD-9ADD40AD2D39Q35356050-FFB6E5FC-F56E-4FA6-8112-B372C9F32A9DQ36024838-636A43B2-9C32-41A4-A97C-1B62F5149E1DQ37337855-F094642C-7A2B-47C5-98A1-6D83E86D142EQ37399494-C7539876-96C5-49BB-891A-BE383BB20A12Q37622236-7CF46F1D-8A2E-4621-8F64-95B1D0C92C8CQ38207008-4A90BB1F-CD23-42A3-A59F-37C50E70CC33Q38261467-15B1234C-17E4-4E68-A47A-24B1AA48D7CDQ40457957-9D78C320-95E1-4358-B145-C5621A58EDCEQ48122263-57A41D7E-975A-4EEA-B6CD-C746832D2B72Q48331178-18768424-1D02-4E07-89BA-3C69353E3BC8Q49584053-394FA081-1A1E-4E2E-AB41-965C1665E870Q50510341-6DCE68AC-747B-461D-8B95-685F5BF23228Q50615051-80200A57-3CD1-4059-BC6B-27B17E96F32EQ52674623-CD909A2A-8AF7-491C-A5F8-25C21DDE5622
P2860
Effects of recombinant human erythropoietin in normal humans.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 31 August 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Effects of recombinant human erythropoietin in normal humans.
@en
Effects of recombinant human erythropoietin in normal humans.
@nl
type
label
Effects of recombinant human erythropoietin in normal humans.
@en
Effects of recombinant human erythropoietin in normal humans.
@nl
prefLabel
Effects of recombinant human erythropoietin in normal humans.
@en
Effects of recombinant human erythropoietin in normal humans.
@nl
P2860
P1476
Effects of recombinant human erythropoietin in normal humans.
@en
P2093
Carsten Lundby
P2860
P304
P356
10.1113/JPHYSIOL.2010.195917
P407
P577
2010-08-31T00:00:00Z